Stock CYH COMMUNITY HEALTH SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Community Health Systems, Inc.

Equities

CYH

US2036681086

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.39 USD +4.31% Intraday chart for Community Health Systems, Inc. +18.53% +8.31%
Apr. 26 UBS Adjusts Community Health Systems Price Target to $3.40 From $3.10, Maintains Neutral Rating MT
Apr. 26 Truist Raises Price Target on Community Health Systems to $3.75 From $3.25, Keeps Hold Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 330.2 854.7 1,692 558 409.2 448.6 - -
Enterprise Value (EV) 1 13,519 12,061 13,325 12,075 11,858 11,924 11,819 11,543
P/E ratio -0.49 x 1.69 x 7.56 x 12.3 x -3.07 x -6.65 x -170 x 12.1 x
Yield - - - - - - - -
Capitalization / Revenue 0.02 x 0.07 x 0.14 x 0.05 x 0.03 x 0.04 x 0.03 x 0.03 x
EV / Revenue 1.02 x 1.02 x 1.08 x 0.99 x 0.95 x 0.96 x 0.91 x 0.84 x
EV / EBITDA 8.3 x 6.67 x 6.77 x 8.24 x 8.16 x 7.76 x 7.28 x 6.63 x
EV / FCF -255 x 6.94 x -22.2 x -105 x - 60 x - -
FCF Yield -0.39% 14.4% -4.5% -0.95% - 1.67% - -
Price to Book -0.15 x -0.59 x -1.28 x -0.43 x -0.31 x -0.37 x -0.42 x -0.53 x
Nbr of stocks (in thousands) 113,878 115,034 127,145 129,157 130,730 132,329 - -
Reference price 2 2.900 7.430 13.31 4.320 3.130 3.390 3.390 3.390
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 13,210 11,789 12,368 12,211 12,490 12,482 12,971 13,685
EBITDA 1 1,628 1,809 1,969 1,466 1,453 1,536 1,624 1,740
EBIT 1 1,020 1,251 1,429 932 948 1,065 1,118 1,205
Operating Margin 7.72% 10.61% 11.55% 7.63% 7.59% 8.53% 8.62% 8.8%
Earnings before Tax (EBT) 1 -430 422 499 349 207 207 280 -
Net income 1 -675 511 230 46 -133 -67.46 -2.56 37.7
Net margin -5.11% 4.33% 1.86% 0.38% -1.06% -0.54% -0.02% 0.28%
EPS 2 -5.930 4.390 1.760 0.3500 -1.020 -0.5100 -0.0200 0.2800
Free Cash Flow 1 -53 1,738 -600 -115 - 198.6 - -
FCF margin -0.4% 14.74% -4.85% -0.94% - 1.59% - -
FCF Conversion (EBITDA) - 96.08% - - - 12.93% - -
FCF Conversion (Net income) - 340.12% - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 3,115 3,233 3,111 2,934 3,025 3,142 3,108 3,115 3,086 3,181 3,140 3,083 3,068 3,228 3,198
EBITDA 1 482 540 409 253 400 404 335 373 360 386 378 379.8 367.1 420.5 381.4
EBIT 1 345 409 281 119 263 268 203 249 232 265 263 255.3 250.8 294.3 266.5
Operating Margin 11.08% 12.65% 9.03% 4.06% 8.69% 8.53% 6.53% 7.99% 7.52% 8.33% 8.38% 8.28% 8.17% 9.12% 8.34%
Earnings before Tax (EBT) 1 154 221 53 -98 70 325 6 40 -33 193 22 61 37 84 45
Net income 1 111 178 -1 -326 -42 414 -51 -38 -91 46 -41 -16.45 -21.5 4.489 -15.93
Net margin 3.56% 5.51% -0.03% -11.11% -1.39% 13.18% -1.64% -1.22% -2.95% 1.45% -1.31% -0.53% -0.7% 0.14% -0.5%
EPS 2 0.8500 1.340 -0.0100 -2.520 -0.3200 3.180 -0.4000 -0.2900 -0.6900 0.3500 -0.3200 -0.1250 -0.1600 0.0350 -0.1200
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 10/27/21 2/16/22 4/27/22 7/27/22 10/26/22 2/15/23 5/1/23 8/2/23 10/25/23 2/20/24 4/24/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 13,189 11,206 11,633 11,517 11,449 11,475 11,371 11,095
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 8.101 x 6.195 x 5.908 x 7.856 x 7.88 x 7.469 x 7.002 x 6.377 x
Free Cash Flow 1 -53 1,738 -600 -115 - 199 - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) -2.37% 3.23% - - - - - -
Assets 1 28,473 15,808 - - - - - -
Book Value Per Share 2 -18.80 -12.50 -10.40 -10.10 -10.20 -9.220 -8.100 -6.450
Cash Flow per Share 3.380 18.60 -1.000 2.310 - - - -
Capex 1 438 440 469 415 467 379 434 478
Capex / Sales 3.32% 3.73% 3.79% 3.4% 3.74% 3.03% 3.35% 3.5%
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Community Health Systems, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3.39 USD
Average target price
4.394 USD
Spread / Average Target
+29.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
COMMUNITY HEALTH SYSTEMS, INC. Stock Community Health Systems, Inc.
+8.31% 449M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CYH Stock
  4. Financials Community Health Systems, Inc.